HB469: AN ACT relating to human gene therapy products and declaring an emergency.
Legislative Summary
Create a new section of KRS Chapter 214 to establish legislative intent; define terms; establish that a person in the Commonwealth shall not administer, by any route or modality, any human gene therapy product for any infectious disease indication, regardless of whether the administration is termed an immunization, vaccine, or any other term; exempt human gene therapy products used to treat cancer or genetic disorders; sunset the provisions on July 1, 2035, unless extended by the General Assembly; EMERGENCY.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
